Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Exceptional Responders With Solid Tumor Cancer

NCT02555735 is registered in ClinicalTrials.gov with Adera Labs, LLC as lead sponsor.

NCT NCT02555735
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02555735 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Exceptional Responders With Solid Tumor Cancer
Lead sponsor
Adera Labs, LLC
Phase
Observational
Overall status
Enrolling by invitation
Start date
October 31, 2015
Completion date
August 31, 2027
Enrollment
250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumor neoplasms